Switch to Maraviroc + Raltegravir

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified July 2013 by University of Maryland
Sponsor:
Information provided by (Responsible Party):
David Riedel, University of Maryland
ClinicalTrials.gov Identifier:
NCT01896921
First received: June 27, 2013
Last updated: July 8, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: July 2016
  Estimated Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)